These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 3276282
1. Antidepressant specificity in atypical depression. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF. Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282 [Abstract] [Full Text] [Related]
2. Phenelzine v imipramine in atypical depression. A preliminary report. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF. Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621 [Abstract] [Full Text] [Related]
3. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG. Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631 [Abstract] [Full Text] [Related]
4. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF. Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132 [Abstract] [Full Text] [Related]
5. Psychopharmacologic validation of atypical depression. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF. J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483 [Abstract] [Full Text] [Related]
6. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF. Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130 [Abstract] [Full Text] [Related]
7. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Leibowitz MR. Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575 [Abstract] [Full Text] [Related]
14. Response to phenelzine among depressed patients with features of hysteroid dysphoria. Kayser A, Robinson DS, Nies A, Howard D. Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817 [Abstract] [Full Text] [Related]
15. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. Stewart JW, Tricamo E, McGrath PJ, Quitkin FM. Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955 [Abstract] [Full Text] [Related]
16. Phenelzine for chronic depression: a study of continuation treatment. Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F. J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558 [Abstract] [Full Text] [Related]
17. A comparison of phenelzine and imipramine in depressed inpatients. Davidson JR, McLeod MN, Turnbull CD, Miller RD. J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542 [Abstract] [Full Text] [Related]